Roh Yeon-hong, Chairman of the Korea Pharmaceutical Bio Association, Re-elected...Starting from March, the 2nd generation starts
Feb 19, 2025
|
|
The Korea Pharmaceutical and Bio Association decided to hold the first board meeting in 2025 at the auditorium on the fourth floor of the association building in Bangbae-dong, Seoul, on the 18th and report to the 80th regular general meeting to be held on the 25th. As a result, Chairman Roh Yeon-hong, who took office as the 22nd chairman in March 2023, will serve a second term from March to February 2027. Earlier, the association's chairman's group recommended Roh as a candidate for the next chairman as his term expires at the end of February this year.
Immediately after the board of directors' resolution to serve consecutive terms, Chairman Roh Yeon-hong said, `I feel a heavy responsibility because I know well what the tasks are assigned to our pharmaceutical bio industry and association.' `I promise to move forward for endless challenges and innovation in line with the industry's efforts to achieve meaningful results in a difficult environment." The association, which started as the Chosun Pharmaceutical Industry Association in October 1945, has been a key pillar of the national health and national economy for the past 80 years and has been with the growth of the pharmaceutical bio industry"We will make every effort to strengthen the role of the association and lead sustainable growth and innovation with member companies so that Korea can become a global pharmaceutical bio powerhouse." he said.
The association's second chairman's meeting and the first board of directors held on the same day deliberated and decided on the 2024 business performance, settlement plan, and 2025 business plan to be presented at the regular general meeting. In particular, the 2025 business plan was created with the concept of preparing the first year implementation plan for the realization of the 'Pharmaceutical Bio Vision 2030' established in January as part of the 80th anniversary of its foundation. In order to implement the association's 2025 business plan, the board of directors also decided on a budget of a total of 12.47 billion won and presented it to the general meeting.
The association will hold the 80th regular general meeting at the auditorium on the 4th floor at 3 p.m. on the 25th to finally vote on the 2025 business plan, budget, 2024 business performance and settlement plan, and revision of the articles of incorporation, including some supplementary revisions, and hold various awards ceremonies for people of distinguished service in the pharmaceutical bio industry.
Chairman Yoon Woong-seop said, "2025 marks the 80th anniversary of the foundation of the Korea Pharmaceutical and Bio Association, and plans to use 2025 as a turning point in designing a sustainable future while shedding new light on the achievements and developments of the industry. We ask for your encouragement and support to make 2025 the first year of industrial leap forward."
This article was translated by Naver AI translator.
